<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211117053085N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-12-20</date_registration>
      <primary_sponsor>university of Lahore</primary_sponsor>
      <public_title>Effects of sacroiliac mobilization versus thrust manipulation on pain and functional disability in female patients with sacroiliac joint dysfunction</public_title>
      <acronym></acronym>
      <scientific_title>Effects of sacroiliac mobilization versus high velocity low amplitude thrust manipulation on pain and functional disability in female patients with sacroiliac joint dysfunction: A randomized controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-08-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>72</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/60558</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: computer generated randomization method will be used to allocate our participants in 2 groups. We will use computer software which will randomly allocate our subjects into either experimental group 1 or experimental group 2. Experimental group 1 will receive Mobilization along with Routine physical therapy while Experimental Group 2 will receive High Velocity Low Amplitude Thrust Manipulation along with routine physical therapy, Blinding description: the care giver and outcome assessor will be unaware of treatment given to participants. We will not disclose to the care giver or the outcome assessor about the type of treatment given to patient. In this way they will be blinded.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Sacroiliac joint Dysfunction.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: 1 will receive Mobilization along with Routine physical therapy. In routine physical therapy we will use electro therapeutic modalities and simple pelvic stabilization exercises. The intervention will be applied 3 sessions per week for 4 weeks. Intervention 2: Intervention group: 2 will receive High Velocity Low Amplitude Thrust Manipulation along with routine physical therapy. In routine physical therapy we will use electro therapeutic modalities and simple pelvic stabilization exercises. The intervention will be applied 3 sessions per week for 4 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Effects of Sacroiliac Mobilization versus high velocity low amplitude thrust manipulation on Pain, and functional Disability in female patients with Sacroiliac joint Dysfunction: A randomized controlled trial
All collectedDeidentified IPD will be shared

When:
it will be available after the completion of work for three years upon request to the person involved in scientific inquiries

To whom:
People working in academic institutes or involved in doing research work

Conditions:
it can be used for citations

Where to obtain:
data can be obtained through email using mail address of dr.nusratqamar55@gmail.com

How to obtain:
data can be obtained through e mail to dr.nusratqamar55@gmail.com

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Wajida Parveen</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Defence Road Sialkot</address>
        <city>Sialkot</city>
        <country1>Pakistan</country1>
        <zip>51310</zip>
        <telephone>092333507157</telephone>
        <email>wajopri@gmail.com</email>
        <affiliation>Sialkot college of physical therapy</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nusrat Qamar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>defence road Sialkot</address>
        <city>Sialkot</city>
        <country1>Pakistan</country1>
        <zip>51310</zip>
        <telephone>0923316678454</telephone>
        <email>dr.nusratqamar55@gmail.com</email>
        <affiliation>Sialkot College of physical therapy</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with confirmed clinical diagnosis of sacroiliac joint dysfunction will be included
Patients presenting with acute pain from last four weeks in low back or Sacroiliac joint of iliac origin
Patients with the complain of hypomobility of sacroiliac joint Will be included in our study
Females from age 25 to 50 years will be included in our study</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>50 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Patients with vertebral bone pathology,radiculopathy,sciatica, recent fracture will not be included in our study
Patients with history of recent surgery in lumbosacral or pelvic area
Females with history of osteoporosis or cancer or any other bone pathology will not be included
Pregnant women, or those who had recent infection will not be included in our study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M46.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Sacroiliitis, not elsewhere classified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: 1 will receive Mobilization along with Routine physical therapy. In routine physical therapy we will use electro therapeutic modalities and simple pelvic stabilization exercises. The intervention will be applied 3 sessions per week for 4 weeks.</i_keyword>
      <i_keyword>Intervention group: 2 will receive High Velocity Low Amplitude Thrust Manipulation along with routine physical therapy. In routine physical therapy we will use electro therapeutic modalities and simple pelvic stabilization exercises. The intervention will be applied 3 sessions per week for 4 weeks</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: outcome will be measured at baseline, 1st, 2nd and 4th weeks post intervention. Method of measurement: pain will be measured using Numeric pain rating scale.</prim_outcome>
      <prim_outcome>Functional Disability. Timepoint: Outcome will be measured at baseline, 1st, 2nd and 4th weeks post interventions. Method of measurement: Functional disability will be measured using Oswestry Disability Index Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>university of Lahore</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-10-27</approval_date>
        <contact_name>Ethics Committee of University of Lahore</contact_name>
        <contact_address>1km off defence road Lahore Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
